Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study

被引：0
|
作者：
Yaodan Bi
Yinchao Zhu
Shuai Tang
Yuguang Huang
机构：
[1] Peking Union Medical College Hospital,Department of Anesthesiology, Peking Union Medical College and Chinese Academy of Medical Sciences
[2] West China Hospital,Department of Anesthesiology
[3] Sichuan University,undefined
来源：
The Journal of Headache and Pain | / 24卷
关键词：
Migraine; Lipids; Drug target Mendelian randomization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
    Bi, Yaodan
    Zhu, Yinchao
    Tang, Shuai
    Huang, Yuguang
    [J]. JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [2] Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization
    Hu, Xiao
    Zhang, Peng
    Gao, Yuan
    Ding, Wen-Wen
    Cheng, Xue-Er
    Shi, Qian-Qian
    Li, Sheng
    Zhu, Yan-Yu
    Pan, Hai-Feng
    Wang, Peng
    [J]. LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [3] Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
    Shan Luo
    Hugh Simon Lam
    Yap Hang Chan
    Clara Sze Man Tang
    Baoting He
    Man Ki Kwok
    Gabriel M. Leung
    C Mary Schooling
    Shiu Lun Au Yeung
    [J]. BMC Medicine, 21
  • [4] Discovery and Exploration of Lipid-Modifying Drug Targets for ALS by Mendelian Randomization
    Jiang, Zheng
    Gu, Xiao-Jing
    Su, Wei-Ming
    Duan, Qing-Qing
    Yin, Kang-Fu
    Ren, Yan-Lin
    Wang, Yi
    Cao, Bei
    Chen, Yong-Ping
    [J]. MOLECULAR NEUROBIOLOGY, 2024, 61 (09) : 6572 - 6583
  • [5] Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
    Luo, Shan
    Lam, Hugh Simon
    Chan, Yap Hang
    Tang, Clara Sze Man
    He, Baoting
    Kwok, Man Ki
    Leung, Gabriel M.
    Schooling, C. Mary
    Au Yeung, Shiu Lun
    [J]. BMC MEDICINE, 2023, 21 (01)
  • [6] Association of lipid-modifying therapy with risk of obstructive sleep apnea: A drug-target mendelian randomization study
    Zou, Juanjuan
    Qi, Shengnan
    Sun, Xiaojing
    Zhang, Yijing
    Wang, Yan
    Li, Yanzhong
    Zhao, Ze Hua
    Lei, Dapeng
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 485
  • [7] Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
    Cai, Gexiang
    Liu, Jingjing
    Cai, Mengsi
    Shao, Lianyou
    [J]. LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [8] Lipids, lipid-modified drug target genes, and the risk of male infertility: a Mendelian randomization study
    Li, Wei
    Li, Hu
    Zha, Cheng
    Che, Bangwei
    Yu, Ying
    Yang, Jianjun
    Li, Tao
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [9] Genetic association of lipids and lipid-lowering drug target genes with Endometrial carcinoma: a drug target Mendelian randomization study
    Yang, Zhehan
    Chen, Junpan
    Wen, Minghao
    Lei, Jiayuan
    Zeng, Ming
    Li, Sichen
    Long, Yao
    Zhou, Zhiyi
    Wang, Chunyan
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [10] Associations of lipids and lipid-modifying drug target genes with atrial fibrillation risk based on genomic data
    Tao, Yuhang
    Wang, Yuxing
    Yin, Yongkun
    Zhang, Kai
    Gong, Yingchao
    Ying, Hangying
    Jiang, Ruhong
    [J]. LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
12345